Clinical trial
Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 Injection
NCT07349823 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 Injection
- Lead sponsor
- West China Hospital
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- January 26, 2026
- Completion date
- December 31, 2028
- Enrollment
- 47 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.